102 On the other hand, numerous groups are advocating for the incorporation of novel markers, for instance a sophisticated karyotype55 or epigenetic subsets, 27,28 into medical apply. Each one of these novel prognostic and/or predictive styles will need to be validated in cohorts of clients treated with focused agents.Dilisensikan di tiga yurisdiks